Barclays’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $196M | Sell |
4,584,260
-439,897
| -9% | -$23.9M | 0.04% | 306 |
|
|
2026
Q1 | $315M | Buy |
5,024,157
+663,465
| +15% | +$53.1M | 0.08% | 193 |
|
|
2025
Q4 | $416M | Sell |
4,360,692
-159,259
| -4% | -$15.6M | 0.1% | 152 |
|
|
2025
Q3 | $441M | Buy |
4,519,951
+152,500
| +3% | +$15.8M | 0.1% | 146 |
|
|
2025
Q2 | $469M | Sell |
4,367,451
-1,168,302
| -21% | -$118M | 0.11% | 119 |
|
|
2025
Q1 | $558M | Buy |
5,535,753
+1,121,449
| +25% | +$113M | 0.16% | 89 |
|
|
2024
Q4 | $394M | Buy |
4,414,304
+339,068
| +8% | +$29.8M | 0.11% | 121 |
|
|
2024
Q3 | $342M | Buy |
4,075,236
+83,063
| +2% | +$6.55M | 0.09% | 159 |
|
|
2024
Q2 | $307M | Sell |
3,992,173
-54,345
| -1% | -$3.98M | 0.09% | 160 |
|
|
2024
Q1 | $277M | Buy |
4,046,518
+671,795
| +20% | +$43.2M | 0.1% | 180 |
|
|
2023
Q4 | $195M | Sell |
3,374,723
-798,464
| -19% | -$42.6M | 0.07% | 242 |
|
|
2023
Q3 | $220M | Buy |
4,173,187
+413,994
| +11% | +$21.7M | 0.14% | 160 |
|
|
2023
Q2 | $203M | Buy |
3,759,193
+2,461,951
| +190% | +$129M | 0.13% | 155 |
|
|
2023
Q1 | $64.9M | Sell |
1,297,242
-901,779
| -41% | -$42.5M | 0.03% | 366 |
|
|
2022
Q4 | $102M | Buy |
2,199,021
+573,278
| +35% | +$24.8M | 0.05% | 272 |
|
|
2022
Q3 | $63M | Buy |
1,625,743
+227,034
| +16% | +$9.11M | 0.07% | 254 |
|
|
2022
Q2 | $52.1M | Sell |
1,398,709
-645,611
| -32% | -$26.3M | 0.03% | 381 |
|
|
2022
Q1 | $90.5M | Sell |
2,044,320
-607,129
| -23% | -$26.3M | 0.07% | 266 |
|
|
2021
Q4 | $113M | Sell |
2,651,449
-169,696
| -6% | -$7.13M | 0.04% | 321 |
|
|
2021
Q3 | $122M | Buy |
2,821,145
+703,594
| +33% | +$31.1M | 0.06% | 271 |
|
|
2021
Q2 | $90.5M | Buy |
2,117,551
+523,967
| +33% | +$22M | 0.04% | 321 |
|
|
2021
Q1 | $61.6M | Buy |
1,593,584
+12,069
| +0.8% | +$457K | 0.03% | 384 |
|
|
2020
Q4 | $56.9M | Sell |
1,581,515
-53,384
| -3% | -$1.92M | 0.03% | 423 |
|
|
2020
Q3 | $62.5M | Buy |
1,634,899
+634,665
| +63% | +$24.5M | 0.04% | 342 |
|
|
2020
Q2 | $35.1M | Sell |
1,000,234
-1,940,660
| -66% | -$69.9M | 0.03% | 427 |
|
|
2020
Q1 | $96M | Buy |
2,940,894
+733,795
| +33% | +$28.7M | 0.08% | 175 |
|
|
2019
Q4 | $99.8M | Buy |
2,207,099
+275,882
| +14% | +$11.5M | 0.06% | 279 |
|
|
2019
Q3 | $78.6M | Sell |
1,931,217
-90,243
| -4% | -$3.82M | 0.05% | 305 |
|
|
2019
Q2 | $86.9M | Buy |
2,021,460
+489,526
| +32% | +$18.8M | 0.05% | 307 |
|
|
2019
Q1 | $58.8M | Buy |
1,531,934
+173,943
| +13% | +$6.64M | 0.04% | 396 |
|
|
2018
Q4 | $48M | Sell |
1,357,991
-248,633
| -15% | -$9.02M | 0.04% | 395 |
|
|
2018
Q3 | $61.9M | Sell |
1,606,624
-435,464
| -21% | -$15.2M | 0.04% | 337 |
|
|
2018
Q2 | $66.8M | Sell |
2,042,088
-121,996
| -6% | -$3.68M | 0.06% | 277 |
|
|
2018
Q1 | $59.1M | Sell |
2,164,084
-139,527
| -6% | -$3.79M | 0.05% | 355 |
|
|
2017
Q4 | $57.1M | Buy |
2,303,611
+1,429,713
| +164% | +$39.4M | 0.05% | 355 |
|
|
2017
Q3 | $25.5M | Buy |
873,898
+42,724
| +5% | +$1.18M | 0.03% | 567 |
|
|
2017
Q2 | $23M | Buy |
831,174
+185,347
| +29% | +$4.92M | 0.02% | 541 |
|
|
2017
Q1 | $16.1M | Buy |
645,827
+286,715
| +80% | +$6.97M | 0.02% | 642 |
|
|
2016
Q4 | $7.77M | Buy |
359,112
+132,745
| +59% | +$2.9M | 0.01% | 1084 |
|
|
2016
Q3 | $5.39M | Sell |
226,367
-86,871
| -28% | -$2.07M | 0.01% | 1229 |
|
|
2016
Q2 | $7.32M | Sell |
313,238
-199,907
| -39% | -$4.32M | 0.01% | 1035 |
|
|
2016
Q1 | $9.24M | Buy |
513,145
+94,067
| +22% | +$1.65M | 0.01% | 804 |
|
|
2015
Q4 | $7.54M | Buy |
419,078
+164,443
| +65% | +$2.95M | 0.01% | 1044 |
|
|
2015
Q3 | $4.07M | Sell |
254,635
-292,523
| -53% | -$5M | ﹤0.01% | 1508 |
|
|
2015
Q2 | $9.3M | Sell |
547,158
-478,066
| -47% | -$8.54M | 0.01% | 1081 |
|
|
2015
Q1 | $17.4M | Sell |
1,025,224
-144,431
| -12% | -$2.28M | 0.02% | 764 |
|
|
2014
Q4 | $15.2M | Sell |
1,169,655
-394,715
| -25% | -$5.05M | 0.01% | 913 |
|
|
2014
Q3 | $17.2M | Sell |
1,564,370
-66,945
| -4% | -$843K | 0.02% | 815 |
|
|
2014
Q2 | $19.6M | Sell |
1,631,315
-335,768
| -17% | -$4.37M | 0.02% | 712 |
|
|
2014
Q1 | $25.6M | Sell |
1,967,083
-294,138
| -13% | -$3.86M | 0.03% | 563 |
|
|
2013
Q4 | $27.1M | Buy |
2,261,221
+436,942
| +24% | +$5.16M | 0.03% | 598 |
|
|
2013
Q3 | $20.1M | Buy |
1,824,279
+275,048
| +18% | +$2.98M | 0.02% | 670 |
|
|
2013
Q2 | $14.4M | Buy |
+1,549,231
| New | +$13.1M | 0.02% | 830 |
|
Other funds holding BSX
Barclays's BSX Position: Q2 2026 in Review
Barclays reduced its Boston Scientific (BSX) stake by 8.8% in Q2 2026, selling an estimated $23.9M and leaving 4,584,260 shares worth $196M. The position accounts for 0.04% of the portfolio, ranked #306.
Barclays first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $558M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Barclays held 4,584,260 shares of Boston Scientific worth $196M as of Q2 2026.
- Barclays sold 439,897 Boston Scientific shares in Q2 2026, an estimated $23.9M.
- Boston Scientific made up 0.04% of Barclays's portfolio in Q2 2026, its #306 holding.
- Barclays first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Barclays's Boston Scientific position peaked at $558M in Q1 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.